{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:14:53Z","timestamp":1778069693525,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clml.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:14:13Z","timestamp":1768263253000},"page":"e586-e590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corneal Lymphoma in Humans: First Population-Based Evidence of Occurrence and Clinical Characteristics"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2026.01.007_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7819-11-73","article-title":"Orbital lymphoma: diagnostic approach and treatment outcome","volume":"11","author":"Eckardt","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"17","key":"10.1016\/j.clml.2026.01.007_bib0002","doi-asserted-by":"crossref","first-page":"1519\u201134","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2026.01.007_bib0003","article-title":"Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database","volume":"29","author":"Loap","year":"2025","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clml.2026.01.007_bib0004","doi-asserted-by":"crossref","first-page":"187\u201197","DOI":"10.1016\/j.ohc.2004.11.001","article-title":"Ocular adnexal lymphoma: classification, clinical disease, and molecular biology","volume":"18","author":"Bardenstein","year":"2005","journal-title":"Ophthalmol Clin N Am"},{"issue":"2","key":"10.1016\/j.clml.2026.01.007_bib0005","doi-asserted-by":"crossref","first-page":"172\u20119","DOI":"10.1111\/vop.12275","article-title":"Suspected malignant transformation of B lymphocytes in the equine cornea from immune-mediated keratitis","volume":"19","author":"Vallone","year":"2016","journal-title":"Vet Ophthalmol."},{"key":"10.1016\/j.clml.2026.01.007_bib0006","first-page":"e95\u2011103","article-title":"The long-term outcomes of standing superficial keratectomy as the sole treatment of corneal B-cell lymphoma in five horses in the UK: clinical, histopathology, immunohistochemical and molecular findings","volume":"36","author":"De Oliveira","year":"2024"},{"key":"10.1016\/j.clml.2026.01.007_bib0007","first-page":"e346\u201151","article-title":"A case of malignant transformation of equine immune-mediated keratitis to B-cell lymphoma","volume":"35","author":"Lisankis","year":"2023"},{"issue":"4","key":"10.1016\/j.clml.2026.01.007_bib0008","doi-asserted-by":"crossref","first-page":"1028\u201134","DOI":"10.1111\/evj.14446","article-title":"Clinical and morphological features of corneal lymphoma in 26 horses (27 eyes)","volume":"57","author":"Morris","year":"2025","journal-title":"Equine Vet J"},{"issue":"11","key":"10.1016\/j.clml.2026.01.007_bib0009","doi-asserted-by":"crossref","first-page":"e485\u201190","DOI":"10.1111\/eve.13601","article-title":"Primary bilateral corneal T cell lymphoma in a horse","volume":"34","author":"Opgenorth","year":"2022","journal-title":"Equine Vet Educ"},{"issue":"6","key":"10.1016\/j.clml.2026.01.007_bib0010","doi-asserted-by":"crossref","first-page":"541\u201152","DOI":"10.1634\/theoncologist.8-6-541","article-title":"Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"8","author":"Gloeckler Ries","year":"2003","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.clml.2026.01.007_bib0011","doi-asserted-by":"crossref","first-page":"228\u201133","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clml.2026.01.007_bib0012","doi-asserted-by":"crossref","first-page":"11\u201131","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol"},{"issue":"20","key":"10.1016\/j.clml.2026.01.007_bib0013","doi-asserted-by":"crossref","first-page":"4185\u201197","DOI":"10.1182\/bloodadvances.2021004939","article-title":"Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?","volume":"5","author":"Imber","year":"2021","journal-title":"Blood Adv"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:36:37Z","timestamp":1778067397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2152265026000091"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.01.007","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal Lymphoma in Humans: First Population-Based Evidence of Occurrence and Clinical Characteristics","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}